Jan 16, 2017 | Posted in Cell Therapy The first chemically-defined, animal component-free, cell culture medium for T cells SANTA ANA, California – January 17, 2017: Irvine Scientific, a worldwide leader in cell culture media development and manufacturing, today announced the introduction of PRIME-XV® T Cell CDM, the first commercially available chemically-defined, animal component-free medium... Read more
HERCULES, Calif. — January 16, 2017 — Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), a global provider of life science research and clinical diagnostic products, announced today that it has entered into a definitive agreement to purchase RainDance Technologies, Inc. The terms of the acquisition were not disclosed. Bio-Rad expects the transaction to close during... Read more
Hamburg, Germany, January 13, 2017 – On January 9, 2017, William A. Linton was elected as a member of the Supervisory Board of Eppendorf AG, Hamburg, during an extraordinary Shareholders’ Meeting. “With William Linton, we are very pleased to welcome a successful entrepreneur and experienced manager from the life science sector to our Supervisory Board,”... Read more
Acquisition Extends VWR’s High Purity Reagents Capabilities RADNOR, Pa., Jan. 12, 2017 /CNW/ — VWR (NASDAQ: VWR), the leading global independent provider of product and service solutions to laboratory and production customers, announced today that it has acquired SEASTAR CHEMICALS Inc., a manufacturer of high purity reagents used in the global research, laboratory and microelectronics... Read more
Maturity Date Extension and Full Cash Repayment by June 2022 BOTHELL, Wash., Jan. 10, 2017 /PRNewswire/ — BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer, manufacturer and marketer of proprietary clinical grade cell and tissue hypothermic storage and cryopreservation freeze media (“BioLife”), today announced that it has reached an agreement to extend the maturity date and repayment schedule of its outstanding $4 million credit... Read more
Männedorf, Switzerland, January 10, 2017 – The Tecan Group (SIX Swiss Exchange: TECN) announced today that Dr. Klaus Lun, Head of Corporate Development and a member of the Management Board of the Tecan Group since June 2013, has been appointed Head of the Life Sciences Business division. On December 14, 2016, Tecan announced that Dr.... Read more
Männedorf, Switzerland, January 10, 2017 – The Tecan Group (SIX Swiss Exchange: TECN) announced today that Dr. Klaus Lun, Head of Corporate Development and a member of the Management Board of the Tecan Group since June 2013, has been appointed Head of the Life Sciences Business division. On December 14, 2016, Tecan announced that Dr.... Read more
SAN DIEGO and HERCULES, Calif. — January 9, 2017 — Illumina, Inc. (NASDAQ: ILMN) and Bio‑Rad Laboratories, Inc. (NYSE: BIO)(NYSE: BIOb) today announced the launch of the Illumina® Bio-Rad® Single-Cell Sequencing Solution at the J.P. Morgan Healthcare Conference, San Francisco. The comprehensive solution is the first next-generation sequencing (NGS) workflow for single-cell analysis, providing researchers... Read more
News Release FOR IMMEDIATE RELEASE January 9, 2017 For more information contact: Andy Cebulla Director of Investor Relations and Treasurer 952.937.4000 MTS ANNOUNCES THE APPOINTMENT OF MS. MAXIMILIANE STRAUB TO THE BOARD OF DIRECTORS Eden Prairie, Minn. – January 9, 2017 – MTS Systems Corporation (NASDAQ: MTSC), a leading global supplier of high-performance test systems... Read more
Monday, January 9, 2017 MENLO PARK, Calif., Jan. 09, 2017 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (Nasdaq:PACB) today announced a new version of chemistry (V2) and software (V4) for the Sequel™ System. The new release improves the system’s ability to support important applications such as structural variant detection and targeted sequencing—including metagenomics, minor... Read more